{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:19Z","timestamp":1787020879423,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CSPC Ouyi Pharmaceutical Co., Ltd"},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYGD18025"],"award-info":[{"award-number":["ZYGD18025"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Bureau of Sichuan Province","award":["2021JDKP004"],"award-info":[{"award-number":["2021JDKP004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Venous leg ulcers (VLUs) are the most severe manifestation of chronic venous disease, with long healing time and a high recurrence rate. It imposes a heavy burden on patients, their families, and the health care system. Chronic inflammation triggered by sustained venous hypertension is now recognized as the hallmark of chronic venous disease. The anti-inflammatory effect of pentoxifylline may offer a promising avenue to treat VLUs. However, current evidence of pentoxifylline for VLUs is relatively small and of low quality. The aim of this study is to evaluate the efficacy and safety of pentoxifylline for VLUs in the Chinese population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a randomized, double-blinded, double-dummy, multi-center, placebo-controlled clinical trial. A total of 240 patients will be randomized to receive pentoxifylline (400\u00a0mg, twice daily) or placebo for 24\u00a0weeks. All participants will receive diosmin treatment and standard care of VLUs and other comorbidities. The primary outcome is the difference in the wound healing rate within 12\u00a0weeks between pentoxifylline and placebo. Secondary outcomes include (1) percent wound size changes at 12\u00a0weeks, (2) the levels of TNF-\u03b1 and IL-6, (3) venous clinical severity score and chronic venous insufficiency quality of life score, and (4) ulcer recurrence within 24\u00a0weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study would evaluate the efficacy and safety of pentoxifylline for VLUs in the Chinese population. If confirmed, it wound offer another effective and safe therapeutic option for treatment of VLUs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      The trial was registered at the Chinese Clinical Trial Registry (No. ChiCTR-2100053053). Registered on 10 November, 2021,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.aspx?proj=137010\">https:\/\/www.chictr.org.cn\/showproj.aspx?proj=137010<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07547-y","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T05:02:28Z","timestamp":1690952548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of pentoxifylline for chronic venous leg ulcers: study protocol for a multicenter randomized controlled trial in China (ESPECT study)"],"prefix":"10.1186","volume":"24","author":[{"given":"Lihong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-1241","authenticated-orcid":false,"given":"Xingwu","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"key":"7547_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.23736\/S0392-9590.18.03999-8","volume":"37","author":"A Nicolaides","year":"2018","unstructured":"Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part I. Int Angiol. 2018;37:181\u2013254.","journal-title":"Int Angiol"},{"key":"7547_CR2","first-page":"105","volume":"31","author":"E Rabe","year":"2012","unstructured":"Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F, Coordinators VCP. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31:105\u201315.","journal-title":"Int Angiol"},{"key":"7547_CR3","first-page":"3047","volume":"99","author":"Vascular Surgery Group SB, Chinese Medical Association","year":"2019","unstructured":"Vascular Surgery Group SB, Chinese Medical Association. Guidelines for diagnosis and treatment of chronic venous diseases in China. Natl Med J China. 2019;99:3047\u201361.","journal-title":"Natl Med J China"},{"key":"7547_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jvsv.2014.09.008","volume":"3","author":"AJ Lee","year":"2015","unstructured":"Lee AJ, Robertson LA, Boghossian SM, et al. Progression of varicose veins and chronic venous insufficiency in the general population in the Edinburgh Vein Study. J Vasc Surg Venous Lymphat Disord. 2015;3:18\u201326.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"7547_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12325-020-01219-y","volume":"37","author":"AN Nicolaides","year":"2020","unstructured":"Nicolaides AN. The most severe stage of chronic venous disease: an update on the management of patients with venous leg ulcers. Adv Ther. 2020;37:19\u201324.","journal-title":"Adv Ther"},{"key":"7547_CR6","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/ijms19061669","volume":"19","author":"A Mansilha","year":"2018","unstructured":"Mansilha A, Sousa J. Pathophysiological mechanisms of chronic venous disease and implications for venoactive drug therapy. Int J Mol Sci. 2018;19:1669.","journal-title":"Int J Mol Sci"},{"key":"7547_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.113.006898","volume":"130","author":"RT Eberhardt","year":"2014","unstructured":"Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130:333\u201346.","journal-title":"Circulation"},{"key":"7547_CR8","first-page":"575","volume":"109","author":"JC Mayberry","year":"1991","unstructured":"Mayberry JC, Moneta GL, Taylor LM Jr, Porter JM. Fifteen-year results of ambulatory compression therapy for chronic venous ulcers. Surgery. 1991;109:575\u201381.","journal-title":"Surgery"},{"key":"7547_CR9","doi-asserted-by":"crossref","unstructured":"Wu B, Lu J, Yang M, Xu T. Sulodexide for treating venous leg ulcers. Cochrane Database Syst Rev 2016:CD010694.","DOI":"10.1002\/14651858.CD010694.pub2"},{"key":"7547_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.avsg.2017.06.131","volume":"46","author":"R Castro-Ferreira","year":"2018","unstructured":"Castro-Ferreira R, Cardoso R, Leite-Moreira A, Mansilha A. The role of endothelial dysfunction and inflammation in chronic venous disease. Ann Vasc Surg. 2018;46:380\u201393.","journal-title":"Ann Vasc Surg"},{"key":"7547_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1164\/ajrccm.159.2.9804085","volume":"159","author":"LJ Marques","year":"1999","unstructured":"Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U. Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med. 1999;159:508\u201311.","journal-title":"Am J Respir Crit Care Med"},{"key":"7547_CR12","doi-asserted-by":"crossref","unstructured":"Sun SY, Li Y, Gao YY, Ran XW. Efficacy and safety of pentoxifylline for venous leg ulcers: an updated meta-analysis. Int J Low Extrem Wounds 2021:15347346211050769.","DOI":"10.1177\/15347346211050769"},{"key":"7547_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1586\/17512433.2016.1109443","volume":"9","author":"M Ahmadi","year":"2016","unstructured":"Ahmadi M, Khalili H. Potential benefits of pentoxifylline on wound healing. Expert Rev Clin Pharmacol. 2016;9:129\u201342.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"7547_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejphar.2006.02.017","volume":"535","author":"M Fantin","year":"2006","unstructured":"Fantin M, Quintieri L, K\u00fasz E, et al. Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties. Eur J Pharmacol. 2006;535:301\u20139.","journal-title":"Eur J Pharmacol"},{"key":"7547_CR15","first-page":"65","volume":"26","author":"JL Ambrus","year":"1995","unstructured":"Ambrus JL, Stadler S, Kulaylat M. Hemorrheologic effects of metabolites of pentoxifylline (Trental). J Med. 1995;26:65\u201375.","journal-title":"J Med"},{"key":"7547_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346: e7586.","journal-title":"BMJ"},{"key":"7547_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jvsv.2019.12.075","volume":"8","author":"F Lurie","year":"2020","unstructured":"Lurie F, Passman M, Meisner M, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020;8:342\u201352.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"7547_CR18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3390\/biomedicines9111569","volume":"9","author":"H Aleksandrowicz","year":"2021","unstructured":"Aleksandrowicz H, Owczarczyk-Saczonek A, Placek W. Venous leg ulcers: advanced therapies and new technologies. Biomedicines. 2021;9:1569.","journal-title":"Biomedicines"},{"key":"7547_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/wound.2013.0473","volume":"3","author":"I Pastar","year":"2014","unstructured":"Pastar I, Stojadinovic O, Yin NC, et al. Epithelialization in wound healing: a comprehensive review. Adv Wound Care. 2014;3:445\u201364.","journal-title":"Adv Wound Care"},{"key":"7547_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.mcna.2021.04.006","volume":"105","author":"C Schneider","year":"2021","unstructured":"Schneider C, Stratman S, Kirsner RS. Lower extremity ulcers. Med Clin North Am. 2021;105:663\u201379.","journal-title":"Med Clin North Am"},{"key":"7547_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/1358863X15594683","volume":"20","author":"N Hedayati","year":"2015","unstructured":"Hedayati N, Carson JG, Chi YW, Link D. Management of mixed arterial venous lower extremity ulceration: a review. Vasc Med. 2015;20:479\u201386.","journal-title":"Vasc Med"},{"key":"7547_CR22","first-page":"435","volume":"62","author":"JP Harding","year":"2021","unstructured":"Harding JP, Hedayati N. Challenges of treating mixed arterial-venous disease of lower extremities. J Cardiovasc Surg (Torino). 2021;62:435\u201346.","journal-title":"J Cardiovasc Surg (Torino)"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07547-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07547-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07547-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T05:07:06Z","timestamp":1690952826000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07547-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7547"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07547-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial was approved by the Ethics Committee on Clinical Trial, West China Hospital of Sichuan University (No. 2021(1326)) and will be conducted in compliance with the Declaration of Helsinki and the Guidelines for Good Clinical Practice. Written, informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"491"}}